Report Detail

Pharma & Healthcare Global Central Nervous System (CNS) Stimulant Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3843761
  • |
  • 09 December, 2019
  • |
  • Global
  • |
  • 138 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Table of Contents

    1 Market Overview

    • 1.1 Central Nervous System (CNS) Stimulant Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Amphetamine
      • 1.2.2 Cocaine
      • 1.2.3 Caffeine
      • 1.2.4 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Attention Deficit Hyperactivity Disorder (ADHD)
      • 1.3.2 Narcolepsy
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Astellas Pharma
      • 2.1.1 Business Overview
      • 2.1.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Novartis
      • 2.2.1 Business Overview
      • 2.2.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Novartis Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Eli Lilly and Company
      • 2.3.1 Business Overview
      • 2.3.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Biogen
      • 2.4.1 Business Overview
      • 2.4.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Biogen Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Merck
      • 2.5.1 Business Overview
      • 2.5.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Merck Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Celltech
      • 2.6.1 Business Overview
      • 2.6.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Celltech Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Johnson and Johnson
      • 2.8.1 Business Overview
      • 2.8.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 GlaxoSmithKline
      • 2.9.1 Business Overview
      • 2.9.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Perdue Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Thermo Fisher Scientific
      • 2.11.1 Business Overview
      • 2.11.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Roche
      • 2.12.1 Business Overview
      • 2.12.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Roche Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Takeda Pharmaceuticals
      • 2.13.1 Business Overview
      • 2.13.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Sanofi
      • 2.14.1 Business Overview
      • 2.14.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Sanofi Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Shire
      • 2.15.1 Business Overview
      • 2.15.2 Central Nervous System (CNS) Stimulant Drugs Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Shire Central Nervous System (CNS) Stimulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Central Nervous System (CNS) Stimulant Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Central Nervous System (CNS) Stimulant Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Central Nervous System (CNS) Stimulant Drugs Market Analysis by Regions

    • 4.1 Global Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)

    5 North America Central Nervous System (CNS) Stimulant Drugs by Country

    • 5.1 North America Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)

    6 Europe Central Nervous System (CNS) Stimulant Drugs by Country

    • 6.1 Europe Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs by Country

    • 7.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)

    8 South America Central Nervous System (CNS) Stimulant Drugs by Country

    • 8.1 South America Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs by Countries

    • 9.1 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate (2014-2019)

    10 Global Central Nervous System (CNS) Stimulant Drugs Market Segment by Type

    • 10.1 Global Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Amphetamine Sales Growth and Price
      • 10.2.1 Global Amphetamine Sales Growth (2014-2019)
      • 10.2.2 Global Amphetamine Price (2014-2019)
    • 10.3 Cocaine Sales Growth and Price
      • 10.3.1 Global Cocaine Sales Growth (2014-2019)
      • 10.3.2 Global Cocaine Price (2014-2019)
    • 10.4 Caffeine Sales Growth and Price
      • 10.4.1 Global Caffeine Sales Growth (2014-2019)
      • 10.4.2 Global Caffeine Price (2014-2019)
    • 10.5 Others Sales Growth and Price
      • 10.5.1 Global Others Sales Growth (2014-2019)
      • 10.5.2 Global Others Price (2014-2019)

    11 Global Central Nervous System (CNS) Stimulant Drugs Market Segment by Application

    • 11.1 Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Attention Deficit Hyperactivity Disorder (ADHD) Sales Growth (2014-2019)
    • 11.3 Narcolepsy Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Central Nervous System (CNS) Stimulant Drugs Market Forecast (2019-2024)

    • 12.1 Global Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Central Nervous System (CNS) Stimulant Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Central Nervous System (CNS) Stimulant Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Central Nervous System (CNS) Stimulant Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Central Nervous System (CNS) Stimulant Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Forecast (2019-2024)
    • 12.3 Central Nervous System (CNS) Stimulant Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Central Nervous System (CNS) Stimulant Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Central Nervous System (CNS) Stimulant Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Central Nervous System (CNS) Stimulant Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Central Nervous System (CNS) Stimulant Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Central Nervous System (CNS) Stimulant Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Description

      Scope of the Report:
      The worldwide market for Central Nervous System (CNS) Stimulant Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Central Nervous System (CNS) Stimulant Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Astellas Pharma
      Novartis
      Eli Lilly and Company
      Biogen
      Merck
      Celltech
      Pfizer
      Johnson and Johnson
      GlaxoSmithKline
      Perdue Pharma
      Thermo Fisher Scientific
      Roche
      Takeda Pharmaceuticals
      Sanofi
      Shire

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Amphetamine
      Cocaine
      Caffeine
      Others

      Market Segment by Applications, can be divided into
      Attention Deficit Hyperactivity Disorder (ADHD)
      Narcolepsy
      Others

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Central Nervous System (CNS) Stimulant Drugs product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Central Nervous System (CNS) Stimulant Drugs, with price, sales, revenue and global market share of Central Nervous System (CNS) Stimulant Drugs in 2017 and 2018.
      Chapter 3, the Central Nervous System (CNS) Stimulant Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Central Nervous System (CNS) Stimulant Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Central Nervous System (CNS) Stimulant Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Central Nervous System (CNS) Stimulant Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


      Summary:
      Get latest Market Research Reports on Central Nervous System (CNS) Stimulant Drugs. Industry analysis & Market Report on Central Nervous System (CNS) Stimulant Drugs is a syndicated market report, published as Global Central Nervous System (CNS) Stimulant Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Central Nervous System (CNS) Stimulant Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,819.96
      4,229.93
      5,639.91
      3,200.36
      4,800.54
      6,400.72
      378,846.72
      568,270.08
      757,693.44
      263,362.57
      395,043.86
      526,725.14
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report